Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
ADNT · 10-Q filed May 6, 2026

ADNT earnings analysis

What we found in ADNT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Adient's Q2 2026 results showed a strong recovery with net sales increasing to $3.865 billion, up 7% year-over-year, and a turnaround in net income to $27 million from a loss of $335 million a year earlier. Operating margins improved despite some headwinds in production volumes, particularly in the EMEA region. The company is dealing with rising costs but has been able to recover some losses through strategic pricing adjustments.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Improvement
Net sales increased by $254 million, or 7%, year-over-year to $3.865 billion compared to $3.611 billion in Q2 2025.
EPS Turnaround
Reported diluted EPS of $0.52 for Q2 2026, rebounding from a loss of $3.99 in the same quarter last year.
Operating Cash Flow Increase
Operating cash flow was reported at $90 million, compared to a loss of $45 million a year ago.
Reduced Restructuring Costs
Restructuring costs fell 99% to $5 million, down from $351 million in Q2 2025.
Segment Revenue Growth
The Americas segment saw an 11% increase in net sales, reaching $1.884 billion.
Stable Operating Expenses
SG&A expenses decreased by 4% to $138 million from $144 million in the prior year.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Production Volatility
Overall production volumes decreased 0.9% globally, with North America and China seeing significant declines.
Currency Fluctuations
Adient's revenues are affected by foreign currency exchange rates, exposing it to potential financial volatility.
Increased Costs from Geopolitical Factors
Ongoing geopolitical uncertainties, particularly from the Middle East and Ukraine, could elevate costs and disrupt supply chains.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $94 Operating expenses $3 Left as operating profit $3
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$0.52
Gross margin
6.6%
Operating margin
3.3%
Segment
Americas: $1.884B
Segment
EMEA: $1.272B
Segment
Asia: $734M
Guidance

What they said about what is next.

No numerical guidance provided; management comments indicate a watchful approach due to external economic factors.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · August 6, 2025
Adient reported quarterly net sales of $3,741 million and GAAP diluted EPS of $0.43 for the three months ended June 30, 2025, with gross profit of $237 million and operating income of $118 million. Liquidity remains…
10-Q · May 7, 2025
Adient reported revenue of $3,611 million for the quarter ended March 31, 2025 (up $111 million QoQ from ~$3,500M and down $139 million YoY from $3,750M). Gross profit improved to $261 million (7.2% margin) but the…
10-Q · January 28, 2025
Adient reported net sales of $3,495 million for the quarter ended December 31, 2024, down $165 million versus $3,660 million a year earlier. Gross profit fell to $216 million and operating income (EBIT) to $93 million,…
10-Q · August 6, 2024
Adient reported Q3 net sales of $3,716 million and gross profit of $207 million, with operating income of $94 million but a loss attributable to Adient of $(11) million (diluted EPS $(0.12)). Revenue and gross profit…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing ADNT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever